Epilepsy
Conditions
Keywords
pediatric epilepsy, transcutaneous vagus nerve stimulation
Brief summary
The purpose of this study is to determine whether transcutaneous auricular vagus nerve stimulation as a complementary therapy is effective in the treatment of pediatric epilepsy.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed as epilepsy; * With age between 2-18 years old; * The number and dose of the medication was kept constant no less than eight weeks before intervention; * The patients or their guardians can count the frequency of the seizures and finish the study.
Exclusion criteria
* The patient is receiving the VNS therapy; * Accompanied with progressive central nervous system diseases; * Have severe heart, liver ,kidney or blood diseases; * Be pregnant or having the schedule of pregnancy in the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of epileptic seizures | Change from baseline at 8, 16, 24 weeks respectively in frequency of epileptic seizures |
Secondary
| Measure | Time frame |
|---|---|
| Number of participants with adverse events as a measure of safety and tolerability | participants will be followed for the duration of TVNS intervention, an expected average of 8 weeks |
Countries
China